BIOGRAPHY
Luis Puig is Director of the Department of Dermatology, Hospital de la Santa Creu i Sant Pau (HSCSP) and Professor of Dermatology at the Universitat Autònoma de Barcelona (UAB) Medical School, Barcelona, Spain. In the last 20 years Dr Puig has focused on clinical research in the treatment of psoriasis with biological agents, an area in which he is considered a key opinion leader both nationally and internationally, having taught at numerous national and international conferences, workshops, and seminars. The results of his research have been published in numerous articles (h-index = 81; i10 index = 447) https://www.ncbi.nlm.nih.gov/myncbi/1F145qcX7mdQs/bibliography/public/ and book chapters. He has participated in numerous clinical trials on psoriasis, in most cases acting as principal investigator. Dr Puig is member of the Spanish Academy of Dermatology and Venereology, founding member of several of its working groups, and past coordinator of the Spanish Psoriasis Group. He is also an aggregate member of the Spanish Society of Rheumatology and its GEAPSO Group for Research in Psoriatic Arthritis, and of several international societies, including the EADV, AAD, CILAD, ESDR, ASDP, ISDP, and GRAPPA. He is or has been Board Member of the EADV (2013-2019), Co-chair of the Psoriasis Task Force of the EADV (2018-), scientific advisor to the Psoriasis International Network, President of the Psoriasis International Network and the Fondation René Touraine Scientific Board Executive Committee (2016-2020), Vicepresident of the Administration Council of the Fondation René Touraine (2018-2020), Member of the European Dermatology Forum (2017-), Councilor of the International Psoriasis Council (2012-), Board Member of the International Psoriasis Council (2018-), Member of the Education and Steering Committees (2020-2023) of GRAPPA, and Board Member at Large (Derm), GRAPPA (2024-)
SESSIONS
DISCLOSURES
AbbVie – Advisory Board(Fees), Investigator(Grants/Research Funding); Almirall – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Amgen – Advisory Board(Fees), Investigator(Grants/Research Funding); Baxalta Incorporated – Advisory Board(Fees); Biogen – Advisory Board(Fees); Boehringer Ingelheim – Advisory Board(Fees), Investigator(Grants/Research Funding); Celgene – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Fees), Investigator(Grants/Research Funding); Merck Serono – Advisory Board(Fees); MSD – Advisory Board(Fees); Mylan Technologies Inc. – Advisory Board(Fees); Novartis – Advisory Board(Fees), Consultant(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding); Roche Laboratories – Advisory Board(Fees), Investigator(Grants/Research Funding); Samsung – Advisory Board(Fees); Sandoz, a Novartis company – Advisory Board(Fees); Sanofi – Advisory Board(Fees), Investigator(Grants/Research Funding); UCB – Advisory Board(Fees), Investigator(Grants/Research Funding);